Your cart is empty
This newly updated text equips nurses and other health-care professionals to deal with the legal issues they encounter in daily practice.
Informative and relevant, The A-Z of Nursing Law covers all recent changes to the law and legislation that affect the nursing profession. As the only local book of this nature, it has become an invaluable resource for nurse practitioners and other health-care professionals.
Undergraduate and postgraduate nursing students will also find it useful.
Cut to the facts about coronavirus in Corona, False Alarm?, the runaway German bestseller. In June 2020, Corona, False Alarm? exploded into the German market, selling 200,000 copies and 75,000 e-books in six weeks. No other topic dominates our attention as much as coronavirus and COVID-19, the infectious disease it triggers. There's been a global deluge of contradictory opinions, fake news, and politically controlled information. Differing views on the dangers posed by the pandemic have led to deep division and confusion, within governments, society, and even among friends and family. In Corona, False Alarm?, award-winning researchers Dr. Sucharit Bhakdi and Dr. Karina Reiss give clarity to these confusing and stressful times. They offer analysis of whether radical protective measures-including lockdown, social distancing, and mandatory masking-have been justified, and what the ramifications have been for society, the economy, and public health. Dr. Bhakdi and Dr. Reiss provide dates, facts, and background information, including: How Covid-19 compares with previous coronaviruses and the flu virus What infection numbers and the death rate really tell us The challenges around lockdown: Were the protective measures justified? Mandatory mask-wearing: Does the science support it? Does the race for vaccine development make sense? What are the chances of success? Will the vaccine be safe? Will people accept it? Corona, False Alarm? provides you with sound information and substantiated facts-and encourages you to form your own opinion on the corona crisis.
In hierdie werk word gekonsentreer op die gemene onderliggende beginsels van enersyds die verskillende vorme van saaklike sekerheidsregte waar telkens sprake is van 'n bepaalde saak as vermoensobjek waarop die skuldeiser 'n beperkte saaklike sekerheidsreg vestig en in sommige gevalle, danksy sodanige beperkte saaklike sekerheidsreg oor die aldus geidentifiseerde saak van die skuldenaar, 'n preferente en versekerde aanspraak op verhaal uit die opbrengs van daardie sekerheidsobjek het ter voldoening van sy uitstaande skuldvordering. 'n Skuldeiser kan andersyds ook met sy skuldenaar ooreenkom om vermoensobjekte, anders as die objekte van saaklike regte van die skuldenaar, as sekerheidsobjekte te identifiseer. Die vestiging van 'n saaklike sekerheidsreg verander nie die saldo van boedelbates van die skuldenaar waarteen sy skuldeisers verhaal kan neem nie - dit plaas hoogstens 'n kordon om die verhaalbare waarde van die geidentifiseerde sekerheidsobjekte ten gunste van die versekerde preferente skuldeiser. By persoonlike sekerheidsregte word daarteenoor verhaal geneem op bates wat aan 'n ander regsubjek as die primere skuldenaar behoort en wat dus nie deel van die saldo van die skuldenaar se bates vorm nie.
In ""Our Right to Drugs"", Szasz shows how the present drug war started at the beginning of this century, when the US government first assumed the task of protecting people from patent medicines. By the end of World War I the free market in drugs was but a dim memory. Instead of dwelling on the familiar impracticality and unfairness of drug laws, Szasz demonstrates the deleterious effects of prescription laws, which place people under lifelong medical supervision. The result is that most Americans today prefer a coercive and corrupt command drug economy to a free market in drugs. Szasz stresses the consequences of the fateful transformation of the central aim of US drug prohibitions: from protecting the public from being fooled by mis-branded drugs to protecting them from harming themselves by self medication. He emphasises that a free society cannot endure if the state treats adults as if they were truant children and if its citizens reject the values of self-discipline and personal responsibility. After discussing the racial aspects of drug prohibition (eg. drug enforcers are far more likely to accost blacks than whites), Szasz suggests a connection between drug prohibition and the personal dread of the availability of an easy and pleasurable way to commit suicide.
Government rules and inspectors can be an important tool to ensure trust in markets, and to protect citizens against hazards. There is, however, a perception that businesses and individuals only comply with rules because of the threat of punishment. From Chasing Violations to Managing Risks examines what actually makes people change their behaviour and how to effectively achieve the objectives of regulations. Building on decades of research, Florentin Blanc examines the development of inspection institutions and their practices, and assesses their varying effectiveness, and the reasons behind this. Bringing together historical, theoretical, and practical perspectives, Blanc provides 'large scale' testing of models through comparative case studies considering practices and their outcomes. By examining case studies, Blanc also assesses how inspection institutions might accomplish better results with less bureaucracy, comparing in particular occupational safety across France, Germany and Great Britain, identifying the key differences between the three, and asking how Britain has achieved a better safety record with fewer inspections (but more efforts to manage risks through other instruments). This book will be invaluable for practitioners of regulatory reform and public administration, as well as for students and researchers of these topics who will benefit from the unique synthesis of historical, theoretical and practical perspectives on the subject.
A concise history of how American law has shaped-and been shaped by-the experience of contagion"Contrarians and the civic-minded alike will find Witt's legal survey a fascinating resource"-Kirkus, starred review "Professor Witt's book is an original and thoughtful contribution to the interdisciplinary study of disease and American law. Although he covers the broad sweep of the American experience of epidemics from yellow fever to COVID-19, he is especially timely in his exploration of the legal background to the current disaster of the American response to the coronavirus. A thought-provoking, readable, and important work."-Frank Snowden, author of Epidemics and Society From yellow fever to smallpox to polio to AIDS to COVID-19, epidemics have prompted Americans to make choices and answer questions about their basic values and their laws. In five concise chapters, historian John Fabian Witt traces the legal history of epidemics, showing how infectious disease has both shaped, and been shaped by, the law. Arguing that throughout American history legal approaches to public health have been liberal for some communities and authoritarian for others, Witt shows us how history's answers to the major questions brought up by previous epidemics help shape our answers today: What is the relationship between individual liberty and the common good? What is the role of the federal government, and what is the role of the states? Will long-standing traditions of government and law give way to the social imperatives of an epidemic? Will we let the inequities of our mixed tradition continue?
Offers a guide to current environmental health and safety statutes--providing a working knowledge of the major legislations and regulations and demonstrating the steps necessary for compliance. Illustrates overall health and safety management skills for multimedia facilities.
As public health professionals around the world work tirelessly to respond to the COVID-19 pandemic, it is clear that traditional methods of contact tracing need to be augmented in order to help address a public health crisis of unprecedented scope. Innovators worldwide are racing to develop and implement novel public-facing technology solutions, including digital contact tracing technology. These technological products may aid public health surveillance and containment strategies for this pandemic and become part of the larger toolbox for future infectious outbreak prevention and control. As technology evolves in an effort to meet our current moment, Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies-a rapid research and expert consensus group effort led by Dr. Jeffrey P. Kahn of the Johns Hopkins Berman Institute of Bioethics in collaboration with the university's Center for Health Security-carried out an in-depth analysis of the technology and the issues it raises. Drawing on this analysis, they produced a report that includes detailed recommendations for technology companies, policymakers, institutions, employers, and the public. The project brings together perspectives from bioethics, health security, public health, technology development, engineering, public policy, and law to wrestle with the complex interactions of the many facets of the technology and its applications. This team of experts from Johns Hopkins University and other world-renowned institutions has crafted clear and detailed guidelines to help manage the creation, implementation, and application of digital contact tracing. Digital Contact Tracing for Pandemic Response is the essential resource for this fast-moving crisis. Contributors: Joseph Ali, JD; Anne Barnhill, PhD; Anita Cicero, JD; Katelyn Esmonde, PhD; Amelia Hood, MA; Brian Hutler, Phd, JD; Jeffrey P. Kahn, PhD, MPH; Alan Regenberg, MBE; Crystal Watson, DrPH, MPH; Matthew Watson; Robert Califf, MD, MACC; Ruth Faden, PhD, MPH; Divya Hosangadi, MSPH; Nancy Kass, ScD; Alain Labrique, PhD, MHS, MS; Deven McGraw, JD, MPH, LLM; Michelle Mello, JD, PhD; Michael Parker, BEd (Hons), MA, PhD; Stephen Ruckman, JD, MSc, MAR; Lainie Rutkow, JD, MPH, PhD; Josh Sharfstein, MD; Jeremy Sugarman, MD, MPH, MA; Eric Toner, MD; Mar Trotochaud, MSPH; Effy Vayena, PhD; Tal Zarsky, JSD, LLM, LLB
The Firearms Law Handbook covers all aspects of the law relating to the use of firearms in Britain. Those who enforce and apply the law will find it of invaluable assistance in their work. The reader who handles and sells guns, both commercially or for sport, will find everything they need to know here. Although the subjects covered can be complex, the book is written in an approachable style to be understood by all of those with an interest in the subject. The classification of firearms is covered in detail, as are the many different circumstances in which authority to possess firearms and ammunition can, and should, be granted. This book will be useful for individuals; those who run shooting clubs and clay grounds; collectors; registered firearms dealers, lawyers and those who require the authority of the Secretary of State to possess prohibited weapons. The rules governing shooting by young persons are considered, together with the various exemptions available where a certificate is not required. Since the seventh edition of this work in 2011 there have been significant changes to firearms legislation which are covered in full, including key changes in the Policing and Crime Act 2017 including new definitions of 'firearm'; 'component part'; 'deactivated weapon' and 'antique firearm'. The book covers all decisions of the higher courts regarding this area since 2011 and deals with the likely effects of the UK leaving the European Union. Police policy on the licensing of firearms is covered in addition to the process of application and appeal to the Crown Court.
Combining the insights of leading legal scholars and public health experts, this timely book provides up-to-date analysis of the various legal problems emerging at different levels of governance (international, European and national) in the context of the regulation of e-cigarettes. Expert contributors investigate the possible application of the precautionary and harm reduction principles in this area, examining the legal constraints imposed on states by international and European rules, as well as the regulatory approaches currently in place in selected national jurisdictions. This ground-breaking book offers an interdisciplinary approach to the topic, combining insights from medical, public health and legal perspectives. The Regulation of E-cigarettes will be essential reading for both legal and public health scholars and students. Providing a comprehensive and in-depth assessment of the regulatory solutions applied to e-cigarettes, it will also be a key resource for governmental officials, NGOs and public health advocates.
The health care system in the United States has been called the best in the world. Yet wide disparities persist between social groups, and many Americans suffer from poorer health than people in other developed countries. In this revised edition of Health Disparities in the United States, Donald A. Barr provides extensive new data about the ways low socioeconomic status, race, and ethnicity interact to create and perpetuate these health disparities. Examining the significance of this gulf for the medical community and society at large, Barr offers potential policy- and physician-based solutions for reducing health inequity in the long term. This thoroughly updated edition focuses on a new challenge the United States last experienced more than half a century ago: successive years of declining life expectancy. Barr addresses the causes of this decline, including what are commonly referred to as "deaths of despair"-from opiate overdose or suicide. Exploring the growing role geography plays in health disparities, Barr asks why people living in rural areas suffer the greatest increases in these deaths. He also analyzes recent changes under the Affordable Care Act and considers the literature on how race and ethnicity affect the way health care providers evaluate and treat patients. As both a physician and a sociologist, Barr is uniquely positioned to offer rigorous medical explanations alongside sociological analysis. An essential text for courses in public health, health policy, and sociology, this compelling book is a vital teaching tool and a comprehensive reference for social science and medical professionals.
Modern food governance is increasingly hybrid, involving not only government, but also industry and civil society actors. This book deftly analyzes the unfolding interplay between public and private actors in global and local food governance. Split into three parts, chapters focus on the legitimacy and integrity of private food governance, the hybridization of EU Food Law and hybridization in transnational food governance. Within these key areas, food scholars from diverse disciplinary fields present a fascinating array of original empirical case studies, showing hybrid governance arrangements in China, Europe and North America. Through these practical examples, they consider in detail how the responsibilities and risks inherent in these arrangements are allocated, how their legitimacy is ensured and the effect that they have on industry and government practice. Timely and discerning, this book will appeal to legal students and scholars focusing on regulation and governance and, in particular, those considering its relation to food. It will also provide guidance to policymakers on how to shape and direct the trends, types and outcomes of hybrid food governance.
For this two-volume collection, Professors Avraham, Hyman and Silver have selected seminal contributions by eminent scholars in the fields of law, economics and medicine. The first volume explores the effects of access to healthcare on mortality and clinical outcomes, the financing of healthcare (including payment to providers, expanding costs, health insurance and the provision of long-term care), distribution of spending and expansion of provision. The second volume covers the regulation of healthcare practice, medical malpractice and liability, public health and ethical issues. An authoritative new introduction by the editors illuminates and enhances the selection of articles. The volumes will prove to be an essential tool for researchers, scholars and practitioners interested in the effects of economic and legal constraints and regulation on healthcare.
This two-volume set gathers together some of the most significant contributions to the study of global health law. Global health law is a recent field of research in its own right, encompassing the relatively narrow core of international rules and institutions devoted to health protection and promotion, as well as the complex interactions between health and multiple areas of international law. By bringing such diverse perspectives into a single collection, together with an original introduction by the editor, this book will be an important resource for scholars and practitioners both in public health as well as in legal and policy fields such as trade and investment, human rights and the environment.
This book examines the changing landscape of food governance. Within this landscape, both public and private regulators increasingly encounter one another as markets have become more globalized. While these encounters may often be planned, long-term and lead to positive relationships and outcomes, they can also be accidental collisions that result in antagonistic relationships and crisis. Empirically, this book investigates these public and private encounters in food governance and the institutional challenges they raise. Importantly, it also explores the public policy responses to these issues at the national, supranational and transnational levels, and investigates new forms of private food regulation. Against this empirical backdrop, the contributors provide insights into broader analytical issues that have animated regulatory governance scholarship such as the legitimacy and effectiveness of public and private regulation, the distribution of power in regulatory arrangements, the interaction of layers and networks of regulation and regulatory responses to crisis. This comprehensive book will be of great value to those interested in gaining an interdisciplinary understanding of the empirical area of food governance and the analytical issues of regulatory governance.
Methamphetamine: A Love Story presents an insider's view of the world of methamphetamine based on the life stories of thirty-three adults formerly immersed in using, dealing, and manufacturing meth in rural Oklahoma. Using a respectful tone towards her subjects, Shukla illuminates their often decades-long love affair with the drug, the attractions of the lifestyle, the eventual unsustainability of it, and the challenges of exiting the life. These personal stories reveal how and why people with limited economic means and inadequate resources become entrapped in the drug epidemic, while challenging longstanding societal views about addiction, drugs, drug policy, and public health.
Analyzing the level of claims for clinical negligence in the light of the most recent trends and discovering whether there is indeed a litigation crisis in healthcare, this book is a topical and compelling exploration of healthcare and doctor-patient relationships.
Covering the topics of medicine and the media and the causes of occupational stress among doctors, this volume is a must read for all students of medical law and medical ethics.
This timely Research Handbook provides a critical conceptualization and definition of the growing field of global health law. The Research Handbook forms the first comprehensive study on the treatment of health issues in international legal regimes and explores the role of international law in addressing the most prominent global health challenges. The editors have consciously adopted a holistic approach by including 'soft' norms and informal law-making processes in the Research Handbook's scope to give a realistic account of the normative framework that shapes contemporary global health. Despite following a predominantly legal perspective, the Research Handbook also adopts an interdisciplinary approach by looking at health from a governance perspective and using insights from international relations scholarship in forecasting possible future developments surrounding health law. The Research Handbook features contributions from a team of leading international legal scholars who have experience of approaching the issue of global health from multiple angles. International law scholars who are seeking information on the growing role of health in governance trends will find this Research Handbook to be of great interest. Public health scholars who are researching international legal perspectives on health practice and policy will also find it to be a valuable resource.
The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities - research, manufacturing, information, distribution and pricing - as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies.
There is an understandable tendency or desire to attribute blame when patients are harmed by their own healthcare. However, many cases of iatrogenic harm involve little or no moral culpability. Even when blame is justified, an undue focus on one individual often deflects attention from other important factors within the inherent complexity of modern healthcare. This revised second edition advocates a rethinking of accountability in healthcare based on science, the principles of a just culture, and novel therapeutic legal processes. Updated to include many recent relevant events, including the Keystone Project in the USA and the Mid Staffordshire scandal in the UK, this book considers how the concepts of a just culture have been successfully implemented so far, and makes recommendations for best practice. This book will be of interest to anyone concerned with patient safety, medical law and the regulation of healthcare.
This book provides a detailed and comparative examination of medical patent law and the issues at the heart of the medical treatment exclusion for therapeutic treatments, surgical treatments and diagnostic methods. It first considers the historical basis for exclusion and the development of law and policy in Europe, the United States and other commonwealth countries. The book goes on to provide a detailed analysis of the issues related to new medical technologies, such as gene therapy, dosage regimes, and medical diagnostics, in light of the medical treatment exclusion. Medical Patent Law will strongly appeal to patent agents and attorneys, solicitors and barristers working in patent and intellectual property law and medical law worldwide, as well as medical practitioners and healthcare professionals; scientists, researchers and managers in the chemicals, medical; pharmaceuticals and biotechnology industries. Postgraduates on LLM medical law and intellectual property courses and academics specializing in medical law or patent law, will also find much to interest them.
Thirty years ago, the first edition of the Furrow Health Law casebook quite literally defined the subject of Health Law in the United States. Today this book, cited by the United States Supreme Court and a host of other courts, remains the leading Health Law casebook in American law schools. The new 8th edition provides up-to-date coverage of the field in all of its complexity. The book offers new cases, statutory materials and classroom tested problems, along with succinct and sharpened notes, comments, charts and other teaching materials. It is fully up-to-date as of mid-2018, and it will be supplemented by a regularly updated website and, if appropriate, printed supplements. The book is more comprehensive but shorter than the last edition; you will find that it teaches extremely well. The new edition has been carefully edited to sharpen its coverage while retaining all core materials. It thoroughly updates coverage of current issues in health insurance, accountable care organizations, the ACA, Medicare (including MACRA and "provider compare" websites), Medicaid (including the broader grounds for waivers under the Trump administration), and all the areas of conflict in today's health care political environment. While the casebook retains the structure that has served teachers and students so well, the 8th edition reorganizes the health policy and reform materials and the section on state regulation of insurance and managed care to reflect changes in the law and the industry. The ERISA materials are separated into a distinct chapter, and there is a new chapter that provides an overview of the US healthcare system, along with a primer on health economics, insurance, managed care, and the tools available to policy makers. There is also a new chapter on discrimination and unequal treatment in health care. Issues raising the inequitable distribution of health resources can be found in almost every chapter. The new edition also updates the bioethics materials so that they maintain a focus on the issues that are currently being litigated or legislated, like state conscience clauses, direct challenges to the principles of Roe v. Wade, and medical aid in dying. The casebook is written to challenge teachers and students on all sides of the issues; the authors are a diverse group with no political or philosophical axe to grind. In this edition the five original authors, Barry Furrow (Drexel), Thomas Greaney (Hastings), Sandra Johnson (SLU), Tim Jost (Washington and Lee), and Rob Schwartz (Hastings), are joined by five new authors who will be taking over future revisions of the casebook. These five new coauthors, all renowned for their teaching prowess as well as their academic work in Health Law, are Brietta Clark (Loyola-LA), Erin Fuse Brown (Georgia State), Robert Gatter (SLU), Jaime King (Hastings) and Elizabeth Pendo (SLU).
This abridged edition uses the organization and methods that health law teachers and students have found so helpful over the last seven editions of the casebook. This book is designed specifically for survey courses in health law that aim at introducing students to the full range of health law issues in a single survey course. As with the full casebook, this abridged version includes chapters covering health care quality, access, organization, finance, and bioethics, but some sections and chapters of the full casebook are deleted and note material is less comprehensive. This abridged version is well suited for health law courses taught in law schools with a single health law course and for courses taught in health administration, public health, and medical and other health professions programs.
This guide has earned a reputation amongst South African lawyers as the source of first reference in assessing liability and the quantum of claims. As a subscription publication, new cases are constantly being added, keeping subscribers abreast of new judicial trends and attitudes to these kinds of claims.
Genetically modified organisms (GMOs) are an extraordinary innovation. They raise great expectations of economic prosperity and improved capacity to address pressing problems of poverty and environmental degradation, whilst simultaneously raising great concerns about the type of social and physical world they promise. Finding space in regulation to consider the full range of issues provoked by GMOs is a huge challenge. This book explores the EU's elaborate regulatory framework for GMOs, which extends far beyond the process of their authorisation (or not) for the EU market, embracing disparate legal disciplines including intellectual property, consumer protection and civil liability. The regulation of GMOs also highlights questions of EU legitimacy in a context of multi-level governance, both internally towards national and local government, and externally in a world where technologies and their regulation have global impacts. This book will be of interest to academics and students in both law and social sciences, as well as practising lawyers and policy makers. It addresses questions that are significant for those involved in environmental or food issues, as well as specialists in GMOs.
You may like...
Introduction to US Health Policy - The…
Donald A. Barr Paperback
Public Safety Bomb Suit Standard…
Houston P Kortman Hardcover R3,280 Discovery Miles 32 800
Intellectual Property and the New…
Sam F. Halabi Paperback R750 Discovery Miles 7 500
Governing Health - The Politics of…
William G. Weissert, Carol S. Weissert Paperback
Malignant - How Bad Policy and Bad…
Vinayak K. Prasad Hardcover R754 Discovery Miles 7 540
Pathways to a Successful Accountable…
Peter A. Gross Paperback
Public Health Law in South Africa
Sundrasagaran Nadasen Paperback R530 Discovery Miles 5 300
My Quest for Health Equity - Notes on…
David Satcher Hardcover R477 Discovery Miles 4 770
Infiltrating Healthcare - How Marketing…
Quinn Grundy Hardcover
Depleted Uranium Weapons and…
Avril McDonald, Brigit C. A. Toebes, … Hardcover